Scientists test 'Mosaic' flu shot aiming for wider protection
NCT ID NCT05968989
Summary
This early-stage study tested the safety and immune response of an experimental flu vaccine called FluMos-v2. The vaccine is designed to protect against six different flu strains, potentially offering broader coverage than current shots. Thirty healthy adults received two doses and were closely monitored for side effects and immune reactions over ten months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.